Syncrosome offers relevant disease models, cutting-edge techniques, specific Biomarkers and a comprehensive background of physiopathology to assist drug discovery companies in selecting their compounds.
Our main activities consist in :
– In vivo Drug Efficacy Studies for:
o CNS,
o Cardiometabolism,
o Gastro and Respiratory
– CNS-PK with a special focus in the study of the Blood Brain Barrier passage and/or Neurotransmitter monitoring.
– Early (PK/PD) on rodents and non-rodents species